MAR as a biomarker in multiple myeloma patients
Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation, Nature Communications (2017).

  MAR as a cancer biomarker
Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate, Nature Biotechnology (2016)

   SMR platform for measuring Mass Accumulation Rate (MAR)
High-throughput single-cell growth measurements via serial microfluidic mass sensor arrays, Nature Biotechnology (2016)

  Focusing on minimal residual disease
Targeting minimal residual disease: a path to cure?, Nature Reviews Cancer (2018).